4.7 Review

Metabolites: messengers between the microbiota and the immune system

Journal

GENES & DEVELOPMENT
Volume 30, Issue 14, Pages 1589-1597

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.284091.116

Keywords

immune; metabolites; microbiome

Funding

  1. Yael and Rami Ungar, Israel
  2. Gurwin Family Fund for Scientific Research
  3. Leona M. and Harry B. Helmsley Charitable Trust
  4. Crown Endowment Fund for Immunological Research
  5. estate of Jack Gitlitz
  6. estate of Lydia Hershkovich
  7. Benoziyo Endowment Fund for the Advancement of Science
  8. Adelis Foundation
  9. Pacific Palisades
  10. Alan Markovitz, Canada
  11. Cynthia Adelson, Canada
  12. Centre National de la Recherche Scientifique (CNRS)
  13. estate of Samuel and Alwyn J. Weber
  14. Mr. and Mrs. Donald L. Schwarz, Sherman Oaks
  15. European Research Council
  16. Kenneth Rainin Foundation
  17. German-Israel Binational Foundation
  18. Israel Science Foundation
  19. Minerva Foundation
  20. Rising Tide foundation
  21. Alon Foundation scholar award

Ask authors/readers for more resources

The mammalian intestine harbors one of the largest microbial densities on Earth, necessitating the implementation of control mechanisms by which the host evaluates the state of microbial colonization and reacts to deviations from homeostasis. While microbial recognition by the innate immune system has been firmly established as an efficient means by which the host evaluates microbial presence, recent work has uncovered a central role for bacterial metabolites in the orchestration of the host immune response. In this review, we highlight examples of how microbiota-modulated metabolites control the development, differentiation, and activity of the immune system and classify them into functional categories that illustrate the spectrum of ways by which microbial metabolites influence host physiology. A comprehensive understanding of how microbiota-derived metabolites shape the human immune system is critical for the rational design of therapies for microbiota-driven diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available